Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients… (NCT07516691) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health System Through the ORTIF Digital Teleconsultation Solution
France250 participantsStarted 2026-05-01
Plain-language summary
The prevalence of HIV (Human Immunodeficiency Virus) and STIs (Sexually Transmitted Infections) is very high in the trans population, due to multifactorial components.
The main risk factors for HIV in this population are unprotected receptive and insertive anal intercourse, multiple sexual partners, sex work, needles share for injecting drugs and hormones.
Physical violence, sexual assault and lack of social and family support are supplementary social risk factors.
Healthcare access is very limited in this socio-economic context. The population of transgender persons and their transmission chains (partners, clients, etc.) are highly exposed to HIV risk, but they are still "hidden" populations, not targeted by prevention programs.
Innovative preventive strategies can improve sexual health services access for these specific populations.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
'For population of E-prevent telemedicine service users :
* Individuals aged ≥18 years
* Registered on a trans escort-client dating website or having sexual relations with trans individuals in exchange for money
* Agreeing to complete at least one teleconsultation through the E-PrevenT program
* Agreeing to provide a phone number and an email address for the teleconsultation
* No verbal objection to participating in the study
For population of trans individuals invited to collaborate in the study (seeds of the RDS strategy):
* Trans or non-binary individuals aged ≥18 years
* Engaged in sexual activity in exchange for money (sex work)
* Commitment to complete sexual health training sessions (twice per year)
* No verbal objection to participating in the study
Exclusion Criteria:
* Person under guardianship, curatorship or other French legal protections schemes
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of trans sex workers or clients who joined the E-PrevenT system during the study period.